title: Estrogen delays the progression of salt-induced cardiac hypertrophy by influencing the renin-angiotensin system in heterozygous proANP gene-disrupted mice.
abstract: Left ventricular hypertrophy is considered an independent risk factor for cardiac morbidity and mortality, and many studies have shown that women have a lower incidence of left ventricular hypertrophy even after correcting for numerous risk factors. This cardio-protective effect seen in women has been attributed to estrogen, which likely modulates specific growth-promoting systems such as the renin-angiotensin system, and in turn may lead to the prevention of left ventricular hypertrophy. Furthermore, the underlying mechanisms responsible are poorly understood. The aim of the present study was to examine the effect of estrogen in relation to its impact on the development of left ventricular hypertrophy through its interaction with the renin-angiotensin system by using the proANP heterozygous (ANP +/-) mouse as a model of salt-sensitive cardiac hypertrophy. Male, female ANP +/- mice and also ovariectomized female ANP +/- mice treated with oil or estrogen, were fed either a normal or high-salt diet. All four groups exhibited a general suppression of the renin-angiotensin system under the high salt challenge. However, after the 5-week treatment period, marked left ventricular hypertrophy was noted only in the male and oil-injected ovariectomized female ANP +/- mice treated with high salt. Collectively, we provide direct evidence that the differences in cardiac hypertrophy between genders in ANP +/- mice is attributed to estrogen. Furthermore, estrogen may play a key role in slowing down the progression of salt-induced left ventricular hypertrophy in ANP +/- mice, in part, independent of the classical systemic renin-angiotensin system and possibly through other pathways.
authors: Department of Anatomy and Cell Biology, Queen's University, Room 850, Stuart St., Botterell Hall, Kingston, ON, Canada K7L 3N6.
authors: S Jeson
authors: SJ
authors: Sangaralingham
authors: M Yat
authors: MY
authors: Tse
authors: Stephen C
authors: SC
authors: Pang
mesh_terms: D000818:Animals; D009320:Atrial Natriuretic Factor / Q000378:metabolism*; D015152:Blotting, Northern; D015153:Blotting, Western; D002312:Cardiomyopathy, Hypertrophic / Q000139:chemically induced* / Q000378:metabolism; D004591:Electrophoresis, Polyacrylamide Gel; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D010052:Ovariectomy; D015347:RNA Probes; D012333:RNA, Messenger / Q000032:analysis; D012084:Renin-Angiotensin System / Q000502:physiology*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D017673:Sodium Chloride, Dietary / Q000009:adverse effects*
chemical_list: D004967:Estrogens; D015347:RNA Probes; D012333:RNA, Messenger; D017673:Sodium Chloride, Dietary; D009320:Atrial Natriuretic Factor
references: Br J Pharmacol. 1993 Oct;110(2):719-23
references: 8242243
references: Ann Intern Med. 1992 Dec 15;117(12):1016-37
references: 1443971
references: J Clin Hypertens (Greenwich). 2003 Jan-Feb;5(1):24-30
references: 12556650
references: Med Clin North Am. 2004 Sep;88(5):1257-71
references: 15331316
references: Mol Cell Biochem. 2001 Mar;219(1-2):99-105
references: 11354260
references: Am J Physiol Regul Integr Comp Physiol. 2005 Mar;288(3):R759-66
references: 15550614
references: J Hypertens. 2000 Sep;18(9):1319-26
references: 10994763
references: Curr Opin Cardiol. 1994 Sep;9(5):619-26
references: 7987043
references: N Engl J Med. 1990 May 31;322(22):1561-6
references: 2139921
references: Cardiovasc Res. 2002 Feb 15;53(3):709-19
references: 11861041
references: Circulation. 1993 Jun;87(6):1816-28
references: 8389259
references: Arch Intern Med. 1995 Jan 9;155(1):57-61
references: 7802521
references: Circulation. 1995 Aug 1;92(3):380-7
references: 7634452
references: Science. 1995 Feb 3;267(5198):679-81
references: 7839143
references: Hypertension. 1992 May;19(5):456-63
references: 1568764
references: Cardiovasc Res. 2002 Feb 15;53(3):672-7
references: 11861038
references: Am Heart J. 2003 Jan;145(1):125-31
references: 12514664
references: Hypertension. 1997 Jan;29(1 Pt 2):394-400
references: 9039133
references: Hypertension. 2006 May;47(5):901-11
references: 16585423
references: Circulation. 2001 Sep 18;104(12):1419-23
references: 11560859
references: Mol Cell Biochem. 2003 Mar;245(1-2):183-90
references: 12708758
references: Am J Hypertens. 2005 Sep;18(9 Pt 2):134S-141S
references: 16125050
references: Eur Heart J. 1989 Dec;10(12):1110-4
references: 2606119
references: FEBS Lett. 1997 Oct 13;416(1):107-12
references: 9369244
references: Circulation. 1996 Sep 15;94(6):1304-9
references: 8822984
references: J Hypertens. 1995 Sep;13(9):953-5
references: 8586829
references: Cardiovasc Res. 1999 Sep;43(4):838-49
references: 10615411
references: J Hypertens. 1997 Jul;15(7):719-26
references: 9222939
references: Hypertension. 2004 Nov;44(5):746-50
references: 15452027
references: Int J Biochem Cell Biol. 2005 Jul;37(7):1357-67
references: 15833268
references: J Hypertens Suppl. 1993 Dec;11(5):S226-7
references: 8158357
references: J Hypertens. 1992 Apr;10(4):361-6
references: 1316402
references: J Clin Endocrinol Metab. 1987 Jul;65(1):1-5
references: 3294878
references: J Hum Hypertens. 2003 Mar;17(3):159-64
references: 12624605
references: Hypertension. 1996 Mar;27(3 Pt 2):523-8
references: 8613197